Rimegepant: Promising Relief for Menstrual Migraines
- 18 hours ago
- 1 min read
Research Summary
A recent study published in BMC Neurology explores the efficacy and safety of rimegepant, a medication, for treating pure menstrual migraine in Chinese women. This retrospective observational study found that rimegepant significantly reduced migraine days by 43% over the study period. Additionally, 62% of participants experienced at least a 50% reduction in headache frequency. The study reports that rimegepant was well-tolerated, with only minor side effects observed in 5% of participants. These findings suggest that rimegepant could be a promising treatment option for menstrual migraines, providing relief and improving quality of life for affected women.
Study Details
👥 Research Team: Ye W et al.
📚 Published In: BMC Neurol
📅 Publication Date: 2026 Apr 2
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.